Abrorjon Yusupbekov

4 та иш

National Cancer Center of Uzbekistan, Tashkent, Uzbekistan;

1. Complex approach in the treatment of retroperitoneal fibrosarcoma.

   Firdavs Ulmasov, M. Djuraev, Abrorjon Yusupbekov +1

   МақолаSarcoma Diagnosis and TreatmentJournal of Clinical Oncology20170 иқтибос

   ABIABI:AkademIndex/openalex/2017.article.000940

2. Exacerbated prognostic impact of multiple intramural metastasis versus single intramural metastasis of thoracic esophageal squamous cell carcinoma: evidence from an Uzbekistan cohort

   Abrorjon Yusupbekov, Takahiro Shinozuka, E.E. Juraev +4

   МақолаEsophageal Cancer Research and TreatmentSurgery Today20240 иқтибос

   ABIABI:AkademIndex/openalex/2024.article.004426

3. The outcomes of atezolizumab therapy in combination with carboplatin and etoposide for small-cell lung cancer.

   Sergey Kamishov, Mirzagaleb Tillyashaykhov, Abrorjon Yusupbekov +6

   МақолаLung Cancer Research StudiesJournal of Clinical Oncology20240 иқтибос

   ABIABI:AkademIndex/openalex/2024.article.006753

4. Clarithromycin Resistance and Treatment Outcomes in <i>Helicobacter pylori</i> Infections: Molecular Genetic Study From Uzbekistan

   J. A. Ismailova, Abrorjon Yusupbekov, Abrorjon Abdurakhimov +1

   МақолаHelicobacter pylori-related gastroenterology studiesGastroenterology Research and Practice20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.007346